急诊就诊的非致死性药物过量患者:自报过量史与纳洛酮使用情况
该前瞻性先导研究在急诊连续纳入76例因非致死性药物过量就诊的患者,调查其过去六个月物质使用、近期及终生过量史、纳洛酮获取与使用史。结果显示阿片类(56%)、兴奋剂(56%)和大麻(59%)使用率高,自报多物质使用达83%;64%报告至少一次既往过量,39%报告三次及以上终生过量。无自报有意阿片使用者的尿药筛芬太尼阳性率为84%,总体为89%;无自报阿片使用者持有纳洛酮(34% vs. 55%)和知道如何获取纳洛酮(50% vs. 74%)的比例均低于有自报阿片使用史者。作者认为急诊过量就诊时收集的数据可用于指导上游纳洛酮分发和公共卫生举措。
要点
- 76例急诊非致死性药物过量患者中,自报多物质使用率为83%,阿片类、兴奋剂和大麻使用率分别为56%、56%和59%。
- 64%报告至少一次既往过量,39%报告三次及以上终生过量。
- 无自报有意阿片使用者的尿药筛芬太尼阳性率为84%,总体研究人群为89%。
- 无自报阿片使用者持有纳洛酮的比例为34% vs. 有自报阿片使用史者55%,知道如何获取纳洛酮的比例为50% vs. 74%。
- 作者认为在急诊过量就诊时收集的数据可用于指导上游纳洛酮分发和公共卫生举措。
适用人群与场景
- 在急诊接受非致死性药物过量治疗并同意研究的连续患者样本,于急诊就诊时前瞻性招募。
研究设计与关键结果
- 前瞻性先导研究,连续纳入76例因非致死性药物过量在急诊就诊的患者,招募历时七个月。
- 参与者报告过去六个月阿片类使用56%、兴奋剂使用56%、大麻使用59%;自报多物质使用(自报使用超过一种物质)为83%。
- 64%报告至少一次既往过量,39%报告在本次索引过量急诊就诊前有三次及以上终生过量。
- 无自报有意阿片使用(n=32)者尿药筛芬太尼阳性率为84%,总体研究人群(n=74)为89%。
- 无自报过去六个月阿片使用者持有纳洛酮的比例为34% vs. 有自报阿片使用史者55%,知道如何获取纳洛酮的比例为50% vs. 74%。
证据类型、等级与局限
- 证据类型:前瞻性先导研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急诊过量就诊时收集的数据可用于指导上游纳洛酮分发和公共卫生举措。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In the context of polysubstance use and fentanyl detection in non-opioid drugs supplies (e.g., cocaine, methamphetamine), it is important to re-evaluate and expand our understanding of which populations are at high risk for fatal drug overdoses. The primary objective of this pilot study was to gather data from the ED to characterize the population presenting with drug overdose, including demographics, drug use patterns and comorbidities, to inform upstream overdose prevention efforts.
METHODS: A consecutive sample of ED patients undergoing treatment for non-fatal overdose were prospectively recruited for study participation at the time of ED visit. Participants reported history of substance use over the past six months, recent and lifetime overdose, and naloxone receipt and administration history.
RESULTS: A total of 76 eligible participants were enrolled over the course of seven months. Participants reported high rates of opioid (56%), stimulant (56%), and cannabis use (59%). Self-reported polysubstance use, defined as self-reported use of more than one substance, was 83%. Of enrolled participants, 64% reported at least one overdose and 39% reported three or more lifetime overdoses prior to their index overdose ED visit. Participants with no self-reported intentional opioid use (n = 32) in the past six months had fentanyl positive urine drug screen 84% of the time versus 89% in the overall study population (n = 74). Participants who did not report opioid use in the past six months were less likely to possess (34% vs. 55%) or to know how to acquire (50% vs. 74%) naloxone compared to participants with self-reported history of opioid use.
CONCLUSION: This study demonstrated high rates of fentanyl exposure on toxicology testing at time of overdose across all participants including study participants without self-reported intentional opioid use. Data gathered in the ED at time of overdose can be used to inform upstream naloxone distribution and public health initiatives.
参考来源
- Pappalardo FS, Krieger M, Park C, et al. Patients presenting to the ED with nonfatal drug overdose: Self-reported history of overdose and naloxone use. Am J Emerg Med. 2024. PMID: 38759250. doi:10.1016/j.ajem.2024.05.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。